# P30 Administrative Supplement COE Cancer Controls: Increasing Tobacco and Lung Cancer Screening through patient Navigation

> **NIH NIH P30** · UNIVERSITY OF MARYLAND BALTIMORE · 2021 · $341,272

## Abstract

Project Summary/Abstract:
There is a critical need to assist Marylanders navigate through treatment options related to tobacco
cessation and lung cancer screening. The University of Maryland Greenebaum Comprehensive
Cancer Center (UMGCCC) senior leadership, including its director, Dr. Kevin Cullen, strongly support
the idea of establishing an organized approach to tobacco cessation and lung cancer screening in
Maryland. This project works to increase lung cancer screening using low-dose CT scan to eligible
adults from UMGCCC’s catchment area. UMGCCC’s catchment area serves 5.4 million
Marylanders living in a 10-county region of central Maryland. The area surrounds UMGCCC in
Baltimore City, includes the Baltimore-DC corridor, and the Maryland State capital of Annapolis
 The proposed work will form a partnership between the UMGCCC’s Office of Community
Outreach and Engagement, the Maryland Cancer Collaborative, and the Maryland Patient Navigator
Network (PNN). The project will provide training to the PNN of 282 patient navigators to utilize
communication, tobacco cessation, and LDCT screening strategies. This will increase referrals to the
Maryland Quitline and refer eligible individuals to lung cancer screening services. This work aims to
increase the proportion of high-risk adults (50-80 years old with a 20-pack-year history of smoking or
those who quit within the last 15 years) screened for lung cancer and support and to implement CDC-
recommended evidence-based interventions that reduce tobacco use and increase the demand for
cessation.
 The lung cancer screening rate currently site at 8.3% in Maryland. Our goal is to utilize
the trained patient navigators to help refer eligible Marylanders to get screened and increase
this percentage to 16.8% This can happen if the 282 Patient Navigators refer and average of 10
eligible Marylanders. Patient Navigators can also amplify the tobacco cessation messaging
utilizing CDC recommended evidence-based interventions.
 Evaluation will be guided by the RE-AIM Framework, with a focus on adoption, reach,
and implementation. The Quitline and LDCT interventions are evidence-based with the
emphasis falling on implementation outcomes. The project will be sustained after the grant
period ends through Comprehensive Cancer Control Coalition patient navigator structures and
evaluation activities, as well as through UMGCCC Community Outreach and Engagement data
collection activities.

## Key facts

- **NIH application ID:** 10407827
- **Project number:** 3P30CA134274-14S3
- **Recipient organization:** UNIVERSITY OF MARYLAND BALTIMORE
- **Principal Investigator:** KEVIN J. CULLEN
- **Activity code:** P30 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $341,272
- **Award type:** 3
- **Project period:** 2008-08-08 → 2026-08-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10407827

## Citation

> US National Institutes of Health, RePORTER application 10407827, P30 Administrative Supplement COE Cancer Controls: Increasing Tobacco and Lung Cancer Screening through patient Navigation (3P30CA134274-14S3). Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/grant/nih/10407827. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*